Previous 10 | Next 10 |
Hologic (HOLX) has completed the acquisition of SOMATEX Medical Technologies for ~$64M. As a result of the acquisition, Hologic will also enhance its sales presence in Europe by expanding its direct channel in Germany and its network of regional and international distributor partners. SOMATEX...
Deal further expands Hologic’s portfolio of world-class breast health solutions addressing the full continuum of care Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company primarily focused on improving women’s health, announced today it ha...
Larry Robbins, Founder and CEO of Glenview Capital Management picks top 10 stock. Glenview Capital 13F portfolio reported a value decline of $22B in the past five years.At the end of the latest quarter, the 13F portfolio value stood ~$3.18B at the end of the latest quarter. Fun...
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present virtually at the 39 th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 11:40 a.m. Eastern Time. The presentation will be webcast live and may be accessed through a link on the inve...
The market essentially finished flat yesterday while investors wait on a possible new stimulus plan. In the meantime, COVID cases are soaring which could lead to more testing after Christmas and New Years. This could be a boon to stocks such as Hologic, Inc. (HOLX), PerkinElmer, Inc. (PKI), a...
Glenview Capital Management’s 13F portfolio value decreased from $3.63B to $3.19B this quarter. The number of positions increased from 43 to 45. They increased Myriad Genetics, while decreasing Quest Diagnostics, DaVita, and United Rentals during the quarter. The top three ...
Even before the COVID-19 outbreak was declared a pandemic, problems with testing plagued this country's response to the coronavirus. During the early stages of the crisis, shortages of the sole federally approved diagnostic (which also had technical issues), tight rules restricting who ...
Studies show new deep-learning algorithm helps radiologists detect breast cancers in their early stages when used with the Genius ® 3D Mammography ™ exam* 1 Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company primarily focused on im...
Leader in women’s health, first in prestigious IMV rankings, to host innovative digital product experiences and medical education sessions Hologic, Inc. (Nasdaq: HOLX) will virtually showcase its extensive portfolio of breast and skeletal health products, including sc...
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present virtually at the 3 rd Annual Evercore ISI HealthCONx Conference on Wednesday, December 2 at 4:20 p.m. Eastern Time. The presentation will be webcast live and may be accessed through a link on the investor...
News, Short Squeeze, Breakout and More Instantly...
2024-07-30 10:30:04 ET BTIG analyst issues NEUTRAL recommendation for HOLX on July 30, 2024 08:28AM ET. The previous analyst recommendation was Neutral. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current an...
2024-07-30 09:30:03 ET RBC Capital analyst issues SECTOR PERFORM recommendation for HOLX on July 30, 2024 07:43AM ET. The previous analyst recommendation was Sector Perform. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus ...
– Revenue of $1,011.4 Million, GAAP Diluted EPS of $0.82, and Non-GAAP Diluted EPS of $1.06; All Met or Exceeded Guidance – – Total Company Revenue Growth of 2.7%, or 3.1% in Constant Currency and 5.8% Organically excluding COVID-19; Against Growth of 18.4% in the Prior Y...